References

  1. Aibinu IE, Ohagbulam VC, Adenipekun EA, Ogunsola FT, Odugbemi TO, Mee BJ. Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria. J ClinMicrobiol. 2003;41(5):2197-2200. PubMed | Google Scholar

  2. Bharat Pokharel M, Janak Koirala, Rajan Dahal K, Shyam Mishra K, Prem Khadga K, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. International Journal of Infectious Diseases. 2006;10:434-438. Google Scholar

  3. Maina Daniel, Makau Paul, Nyerere Andrew, Revathi Gunturu. Antimicrobial resistance patterns in extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates in a private tertiary hospital, Kenya. Microbiology Discovery. 2013;1(5):1-4. PubMed | Google Scholar

  4. Fang Hong, Ataker Ferda, Hedin Go¨ran, Dornbusch Kathrine. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol. 2008;46(2):707-712. PubMed | Google Scholar

  5. Oluduro Anthonia Olufunke, Aregbesola Oladipupo Abiodun, Fashina Christina Dunah. 2014 Extended Spectrum Beta- Lactamase- Producing Uropathogenic Escherichia coli in Pregnant Women Diagnosed With Urinary Tract Infections in South-Western Nigeria. Journal of Molecular Biology Research. 2014;4(1):34-41. PubMed | Google Scholar

  6. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005 Oct;18(4):657-86. Google Scholar

  7. Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006 Apr 15;42 Suppl 4:S164-72. PubMed | Google Scholar

  8. Pitout Johann DD, Nordmann Patrice, Laupland Kevin B, Poirel Laurent. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52-59. Google Scholar

  9. Arzai AH, Adamu DJM. Prevalence of beta-lactamase Producers among randomly selected bacterial pathogens in Kano, Nigeria. Biological and Environmental Sciences Journal for the Tropics. 2008;5(3):218-223. PubMed | Google Scholar

  10. Yusuf I, Haruna M, Yahaya H. Prevalence and antibiotic susceptibility of ampc and ESBL producing clinical isolates at a tertiary health care center in Kano, northwest Nigeria. African Journal of Clinical and Experimental Microbiology. 2013;14(2): 109-119. PubMed | Google Scholar

  11. Iroha IR, Adikwu MU, Esimone CO, Aibinu I, Amadi ES. Extended spectrum Beta-Lactamase (EBSL) in E coli isolated from a tertiary hospital in Enugu state, Nigeria. Pak J Med Sci. 2009; 25(2): 279-282. PubMed | Google Scholar

  12. Afunwa RA, Odimegwu DC, Iroha RI, Esimone CO. Antimicrobial resistance status and prevalence rates of extended spectrum beta-lactamase (ESBL) producers isolated from a mixed human population. Bosn J Basic Med Sci. 2011;11(2):91-6.. PubMed | Google Scholar

  13. Song W, Lee KM, Kang HJ, Shin DH, Kim DK. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 2001;27(2):136-9. PubMed | Google Scholar

  14. Oli Angus Nnamdi, Ekejindu Callistus Chibuike, Ejiofor Obiora Shedrack, Oli Adaobi Helen, Ezeobi Ifeanyi, Ibeh Christian Chibuzo. The knowledge of and attitude to hospital-acquired infections among public and private healthcare workers in South-East, Nigeria. British Journal of Medicine & Medical Research. 2016; 11(3): 1-10. Google Scholar

  15. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N. High rate of fatal pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta lactamases in Dares Salaam, Tanzania. Journal of Clinical Microbiology. 2005;43:745-49. Google Scholar

  16. Leekha Surbhi, Terrell Christine L, Edson Randall S. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86(2):156-167. PubMed | Google Scholar

  17. Cheesbrough Monica (2006) District Laboratory Practice in Tropical Countries Part 2, Second Ed. Cambridge University Press. Google Scholar

  18. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad spectrum β-lactamases conferring transferable resistance to new β-lactam agents in Enterobacteriaceae Hospital prevalence and susceptibility patterns. Rev Infect Dis. 1998;10:867-878. PubMed | Google Scholar

  19. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eleventh Edition. CLSI document M02-A11 (ISBN 1-56238-781-2 [Print]; ISBN 1-56238-782-0 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2012. Google Scholar

  20. Kehinde AO, Ademola SA, Okesola AO, Oluwatosin OM. Pattern of bacterial pathogens in burn wound infections in Ibadan, Nigeria. Annals of Burns and fire disasters. 2004;42:348-355. Google Scholar

  21. Mehedi HM, Arongozeb G, Muktadir K, Zakaria A. Isolation and identification of different bacteria from different types of burn wound infections and study their antimicrobial Sensitivity pattern-IMPACT. International Journal of Research in Applied, Natural and Social Sciences. Aug 2013; 1(3):125-132. Google Scholar

  22. Manjula M, Priya D, Varsha G. Bacterial isolates from burn wound infections and antibiograms: eight year study. Ind J Plastic Surg. 2007;40:22-25. Google Scholar

  23. Ankur Goyal, Prasad KN, Amit Prasad, Sapna Gupta, Ujjala Ghoshal, Archana Ayyagari. Extended spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae & associated risk factors. Indian J Med Res. June 2009;129:695-700. Google Scholar

  24. Mathur P, Tatman A, Das B, Dhavan B. Prevalence of ESBL gram negative bacteria in a tertiary care hospital. Indian J Med Microbiol.2002;115:153-157. Google Scholar

  25. Kumar MS, Lakshmi V, Rajagopalan R. Occurrence of extended spectrum beta lactamases among Enterobacteriaceae spp isolated at a tertiary care institute. Indian J Med Microbiol. 2006 Jul;24(3):208-11. PubMed | Google Scholar

  26. Aggarwal R, Chaudhary U, Bala K. Detection of extended spectrum β- lactamase in Pseudomonas aeruginosa. Indian J Pathol Microbial. 2008;51(2):222-224. PubMed | Google Scholar

  27. Alharbi Sulaiman A, Zayed ME. Antibacterial susceptibility of bacteria isolated from burns and wounds of cancer patients. Journal of Saudi Chemical Society. 2014;18:3-11. PubMed | Google Scholar

  28. Shaikh Sibhghatulla, Fatima Jamale, Shakil Shazi, Mohd Syed, Rizvi Danish, Kamal Mohammad Amjad. Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital. Saudia Journal of Biological Sciences. 2015; 2:62-64. PubMed | Google Scholar

  29. González-López Juan José, Piedra-Carrasco Nuria, Salvador Fernando, Rodríguez Virginia, Sánchez-Montalvá Adrián, Planes Anna M, Israel Molina, Larrosa M. Nieves; ESBL-Producing Salmonella enterica Serovar Typhi in Traveler Returning from Guatemala to Spain.Emerging Infectious Diseases. 2014;20(11):1918-1920. PubMed | Google Scholar

  30. Gautam K, Pokhre BM, Bhatta DR, Shrestha CD. Studies on Extended Spectrum Beta Lactamase (ESBL) producing Salmonella isolates from clinical samples of Nepal. Nepal Med Coll J. 2012;14(3):204-206. PubMed | Google Scholar

  31. Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis. 2007 Nov 1;45(9):1179-81. Epub 2007 Sep 27. PubMed | Google Scholar

  32. Anupurba S, Battacharjee A, Garg A, Ranjansen M. The antimicrobial Susceptibility of Pseudomonas aeruginosa isolated from wound infections. Indian J Dermatol. 2006; 51(4):286-288. PubMed | Google Scholar

  33. Sasirekha B, Monasa R, Ramya P, Sneha R. Frequency and Antimicrobial sensitivity Pattern of Extended Spectrum B-Lactamases Producing Escherichia coli and Klebsiella pneumonia Isolated in A Tertiary Care Hospital, Al Ameen. Journal of Medical Science. 2010;3(4):265-271. PubMed | Google Scholar

  34. Gad GF, Mohamed HA, Ashour HM. Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram-Negative Bacteria from Infected Patients in Upper Egypt. PLoS ONE. 2011; 6(2): e17224. PubMed | Google Scholar

  35. Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenges of ESBLs. Curr Opin Pharmacol. 2007 Oct;7(5):459-69. Epub 2007 Sep 17. PubMed | Google Scholar

  36. Lin Y, Lu M, Hui-Ling, Tang H, Liu H, Chen C, Liu K, Lin C, Chiou C, Chiang M, Chen C, Yi-Chyi, Lai Y. Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain. BMC Microbiology. 2011;11:50. PubMed | Google Scholar

  37. Hill Dominic, Barbara Rose, Aniko Pajkos, Michael Robinson, Peter Bye, Scott Bell, Mark Elkins, Barbara Thompson, Colin MacLeod, Shawn Aaron D, Colin Harbour. Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under aerobic anaerobic and biofilm Conditions. J Clin Microbiol. 2005; 43:5085-5090. PubMed | Google Scholar

  38. Subramani S, Vignesh S. MAR Index Study and MDR Character Analysis of a few Golden Staph Isolates. Asian J Pharmacy and Life Science. April-June 2012; 2(2):151-165. PubMed | Google Scholar

  39. Adegoke AA, Komolafe AO. Multi-drug resistant Staphylococcus aureus in clinical cases in Ile-Ife, Southwest Nigeria. Int J Med Sci. 2009;1(3):68-72. PubMed | Google Scholar